Skip to main content
Signal8

cbdMD, Inc. (YCBD)

cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.

Sector: Perfumes, Cosmetics & Other Toilet Preparations

Industry: Drug Manufacturers - Specialty & Generic

cbdMD, Inc. logo

cbdMD, Inc.

NYSE:YCBDHealthcare
+0.61%$0.3648
AH Close$0.3648+0.00%vs close
Mkt Cap$4.09M
Float11.08M
O/S11.21M
Inst Own8.2%
SI4.9%
Dilution
FormDescription
8-K
10-Q
8-K
10-Q
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
8-K
8.01
8-K
5.02,5.07,9.01
EFFECT
Notice of Effectiveness
424B4
Prospectus
CORRESP
SEC Filing
S-1/A
Registration Statement (Amended)
10-Q
Quarterly Report
DEF 14A
Definitive Proxy Statement
PRE 14A
Preliminary Proxy Statement
UPLOAD
SEC Filing
S-1
Registration Statement
10-K/A
Annual Report (Amended)
424B3
Prospectus
8-K
1.01,3.02,9.01
EFFECT
Notice of Effectiveness

1-25 of 535

…
    cbdMD, Inc. (YCBD) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8